Dr. Kevin Pfleger Discusses Novel nanoBRET Assay Development for High Throughput Screening

Dr. Kevin Pfleger, Associate Professor at the University of Western Australia and Head of Molecular Endocrinology and Pharmacology at Harry Perkins Institute of Medical Research, discusses a recently published, novel nanoBRET assay that was developed in collaboration with BMG Labtech and Promega.